This compound is a nucleoside phosphoramidite designed for use in automated oligonucleotide synthesis. It features a 5'-O-(4,4'-dimethoxytrityl) (DMT) protecting group, a constrained ethyl (cET) modification on the sugar ring, and a 3'-O-(2-cyanoethyl) (OCE) phosphoramidite group, making it suitable for incorporating modified uridine into synthetic RNA strands.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 945628-51-3
5'-ODMT cEt m5U Phosphoramidite (Amidite)
phosphoramidite building block for oligonucleotide synthesis
(1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dioxabicyclo[2.2.1]heptan-7-yl (2-cyanoethyl) diisopropylphosphoramidite
oligonucleotide building block
(2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(hexadecyloxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
Nucleoside phosphoramidite for oligonucleotide synthesis
9-(2,5-Anhydro-4-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-O-((2-cyanoethoxy)(di(propan-2-yl)amino)phosphanyl)-6-deoxy-alpha-L-mannofuranosyl)-2-(2-methylpropanamido)-3,9-dihydro-6H-purin-6-one
Phosphoramidite for oligonucleotide synthesis
4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzoic acid
Momelotinib metabolite M19
4-Ethoxy-3-nitropyridine hydrochloride
Pharmaceutical intermediate for heterocyclic synthesis
3-(Butylamino)-4-(4-hydroxyphenoxy)-5-sulfamoylbenzoic acid
Regorafenib impurity
Dmt-loct phosphoramidite
oligonucleotide building block reagent
3-[[(1S,3R,4R,6S,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-(2,4-dioxopyrimidin-1-yl)-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-7-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
MCMVDDGYNXOEJR-ZDHUYCFVSA-N
C[C@H]1[C@]2([C@H]([C@@H](O1)[C@@H](O2)N3C=CC(=O)NC3=O)OP(N(C(C)C)C(C)C)OCCC#N)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC
—